Page last updated: 2024-08-22

zalcitabine and Chronic Hepatitis B

zalcitabine has been researched along with Chronic Hepatitis B in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J; Sagir, A1
Chan, HL; Lau, TC; Leung, NW; Sung, JJ; Wong, ML1
Cheng, YC; Chevallier, M; Guerret, S; Hantz, O; Jamard, C; King, I; Le Guerhier, F; Peyrol, S; Pichoud, C; Trépo, C; Zoulim, F1

Reviews

1 review(s) available for zalcitabine and Chronic Hepatitis B

ArticleYear
[New approaches in the treatment of hepatitis B].
    Deutsche medizinische Wochenschrift (1946), 2004, May-21, Volume: 129, Issue:21

    Topics: 2-Aminopurine; Adenine; Antiviral Agents; Arabinofuranosyluracil; Carcinoma, Hepatocellular; Contraindications; Deoxycytidine; Emtricitabine; Famciclovir; Guanine; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Organophosphonates; Organophosphorus Compounds; Polyethylene Glycols; Prodrugs; Prognosis; Recombinant Proteins; Tenofovir; Zalcitabine

2004

Trials

1 trial(s) available for zalcitabine and Chronic Hepatitis B

ArticleYear
Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:9

    Topics: Antiviral Agents; DNA, Viral; Emtricitabine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Nucleic Acid Hybridization; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Zalcitabine

2000

Other Studies

1 other study(ies) available for zalcitabine and Chronic Hepatitis B

ArticleYear
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

    Topics: Animals; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Circular; DNA, Viral; Drug Administration Schedule; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Liver; Marmota; Skin Pigmentation; Viremia; Virus Replication; Zalcitabine

2001